Keiretsu Forum

Vartega Inc. specializes in recycling carbon fiber, a material known for its strength and lightweight properties, primarily serving the aerospace, automotive, wind energy, and sporting goods sectors. Founded in 2014 and based in Golden, Colorado, Vartega has developed a patented recycling process that produces low-cost carbon fiber suitable for various applications, including thermoplastic pellets, nonwoven fabrics, yarns, and three-dimensional printing filament. The company’s technology effectively diverts carbon fiber scrap and waste from landfills, contributing to environmental sustainability by reducing greenhouse gas emissions and enhancing fuel economy in vehicles. Vartega's carbon fiber is available in multiple forms, including semi-continuous, chopped, and milled, making it adaptable for mass-market use.

Vartega Inc. specializes in recycling carbon fiber, a material known for its strength and lightweight properties, primarily serving the aerospace, automotive, wind energy, and sporting goods sectors. Founded in 2014 and based in Golden, Colorado, Vartega has developed a patented recycling process that produces low-cost carbon fiber suitable for various applications, including thermoplastic pellets, nonwoven fabrics, yarns, and three-dimensional printing filament. The company’s technology effectively diverts carbon fiber scrap and waste from landfills, contributing to environmental sustainability by reducing greenhouse gas emissions and enhancing fuel economy in vehicles. Vartega's carbon fiber is available in multiple forms, including semi-continuous, chopped, and milled, making it adaptable for mass-market use.

Inmedix, LLC is a company focused on developing diagnostics and therapeutics for autoimmune diseases by assessing and optimizing the autonomic nervous system's (ANS) control of stress responses in the brain. Founded in 2006 and located in Normandy Park, Washington, Inmedix has introduced a novel class of diagnostics and therapeutics aimed at understanding the relationship between ANS stress and autoimmune conditions. This approach, termed Immuno-autonomics, seeks to mitigate the exacerbating effects of stress on autoimmune diseases, enhancing the efficacy of existing therapies. Inmedix offers a cloud-based software platform along with diagnostic devices that track the interaction between stress and immune function, providing valuable insights for clinicians and opportunities in drug discovery.

UbiQD, LLC is a manufacturer of low-hazard semiconductor nanocrystals based in Los Alamos, New Mexico. Founded in 2014, the company specializes in producing low-toxicity quantum dots and polymer composites that are designed for a variety of applications, including agriculture, solar energy, and lighting. One of its key products, UbiGro, is a retrofit luminescent film that can be easily installed in greenhouses to enhance crop growth by optimizing sunlight. UbiQD's focus on creating inexpensive, cadmium-free quantum dots positions it to become a significant player in cleantech materials, facilitating collaborations with leading scientists in the region, particularly from Los Alamos and Sandia National Laboratories.

Light Line Medical, Inc. is a medical device company based in Salt Lake City, Utah, that specializes in manufacturing catheter devices using innovative visible light technology to prevent and treat catheter-associated infections. Founded in 2011, the company develops a visible light phototherapy system designed to disinfect catheters and reduce harmful pathogens that lead to various infections, including urinary tract infections, bloodstream infections, and ventilator-associated pneumonia. The technology is applicable across multiple markets, with initial applications focusing on peritoneal dialysis catheters to combat related infections, followed by Foley catheters and endotracheal tubes. Light Line Medical's products are currently undergoing testing and are in the pre-FDA approval phase, aiming to significantly enhance patient safety and healthcare outcomes by reducing the incidence of device-associated infections.

Vita Inclinata Technologies, Inc. is an aerospace company specializing in solutions for helicopter hoisting and sling load control systems. Founded in 2019 and headquartered in Broomfield, Colorado, with additional offices in Seattle, Washington, and Estonia, the company develops autonomous systems aimed at improving safety and efficiency in helicopter operations across various sectors, including aerospace and construction. Its innovative rescue hoisting system incorporates a proprietary control algorithm that is integrated into the stabilization computer of the helicopter. This technology effectively mitigates the swinging motion of the cable and load, allowing rescuers and medical personnel to provide care with greater stability and precision during critical rescue missions.

KitoTech Medical is a medical device company developing and commercializing products for wound closure and wound care. It has developed and introduced a revolutionary proprietary wound closure product, microMend, onto the market. It incorporates tiny Microstaples on an adhesive backing, which is the size and shape of a butterfly bandage. microMend is painless and as easy to apply as a bandage. The Microstaples provide the holding strength of sutures resulting in secure anchoring of the device to the skin. These features make microMend ideal for closing surgical incisions and lacerations currently closed with sutures and staples. Clinical studies have demonstrated its superiority over sutures in terms of clinical outcomes, including cosmetic results. It is much faster than sutures and can be applied by less costly medical personnel (nurses, PAs, and nursing assistants) translating into significant cost savings in wound closure procedures. microMend is being marketed in a broad range of surgical specialties as well as dermatology and emergency medicine. The military represents an additional major market for microMend, where the product is also being commercialized. Its potential market is over $600M and $2B in the US and worldwide, respectively. KitoTech Medical was founded in 2011 and is based in Seattle, Washington.

HaptX® makes technology that simulates touch sensation with unprecedented realism. HaptX Gloves enable natural interaction and realistic haptic feedback in virtual reality for the first time. Built with patented microfluidic technology, HaptX Gloves feature 130 points of touch feedback, apply 4 lbs. of resistive force feedback per finger, and track hand motions with sub-millimeter precision. Founded by Jake Rubin and Dr. Bob Crockett, HaptX has 35 employees, with offices in Seattle, WA and San Luis Obispo, CA.

OtoNexus Medical Technologies Inc. specializes in the design, development, and commercialization of a patented ultrasound medical device aimed at diagnosing middle ear infections, also known as otitis media, in both children and adults. This innovative device provides clinicians with the ability to differentiate between viral and bacterial infections, facilitating informed decisions regarding the necessity of antibiotics. By employing ultrasound technology in a novel manner, the device delivers rapid diagnosis in seconds and can be utilized by various healthcare professionals, including physicians and non-physician personnel. Additionally, the incorporation of one-use-per-patient tips generates a recurring revenue stream for the company. Founded in 2010 and based in Seattle, Washington, OtoNexus Medical Technologies was previously known as OtoMetrix Medical Technologies before rebranding in July 2014.

Ecellix focuses on providing innovative battery anode materials that aim to replace traditional graphite in lithium-ion batteries. Founded in 2018 and based in Seattle, Washington, the company has developed its eCell™ technology, which incorporates a high silicon content to significantly enhance anode capacity—offering more than three times the capacity of standard graphite anodes. This technology also features exceptional retention capabilities, surpassing industry standards with the potential for thousands of cycles. Additionally, Ecellix’s single-step fabrication process allows for adjustable pore sizes, which can be tailored to optimize energy density and power. By addressing the production challenges associated with high-silicon materials, Ecellix provides battery manufacturers with a solution that improves retention capacity and energy density while reducing manufacturing costs and production times.

Pattern Computer is a pattern discovery company that discovers and generates valuable hypotheses and insights into complex data to transform business or research. They find novel patterns in complex data that cannot be discovered using conventional techniques or tools, even on exascale computers. The company's hypothesis-generating engine is prompting new ways of assessing and solving some of the most difficult and entrenched problems in medical research. Pattern Computer was founded in 2016 and is based in Friday Harbor, Washington.

Kokopelli Outdoor, Inc. is a Denver-based company that specializes in the manufacture of packrafts and related outdoor gear. Founded in 2014, the company focuses on creating high-quality, lightweight, and durable packrafts designed for backpackers, fishermen, and river enthusiasts, facilitating comfortable river travel and alpine lake fishing. In addition to its manufacturing operations, Kokopelli Outdoor organizes packrafting courses and events, enhancing the outdoor experience for its customers. The company also engages in online retail, offering a range of packrafting products to a broader audience.

Precision Image Analysis, Inc., based in Kirkland, Washington, specializes in cloud-based remote medical image post-processing and analysis services for diagnostic medical studies, particularly in CT and MRI imaging. Founded in 2012, the company serves healthcare institutions, universities, and research organizations, providing timely analysis that can be delivered in as little as two hours. Its HIPAA-compliant platform allows users to upload images and monitor their analyses remotely, ensuring efficient workflow and standardized reporting. Precision Image Analysis offers particular expertise in cardiac, vascular, and neuro imaging, allowing healthcare providers to manage image analysis tasks without the need for additional staffing or extensive training on new technology. This capability enables clients to scale their image analysis efforts flexibly and cost-effectively, addressing fluctuations in demand without compromising on quality or efficiency.

BabyPage is an online platform and mobile application based in Albuquerque, New Mexico, that allows parents to capture and track their children's milestones throughout various stages of childhood. Founded in 2016, the app prompts parents with age-specific questions and seasonal themes, utilizing a natural language algorithm to automatically generate content. This feature simplifies the documentation process, enabling parents to easily record their child's development and share digital versions with family and friends or print them as keepsakes. BabyPage aims to create a meaningful way for families to cherish and remember significant moments in their children's lives.

Stream Dx is a medical device company that enables Primary Care Physicians and urologists to deliver high-quality, inexpensive LUTS care. The company helping patients identify BPH by sending easy to use equipment directly to your home. It also handles every step of the data collection process, so physicians can focus on delivering quality care to their patients. The Stream Dx device is a small, self-contained portable device into which patients can void naturally in the comfort of their own homes. The company's meter s a small, self-contained portable device into which patients can void naturally in the comfort of their own homes by checking flow rate and volume data collected, enabling healthcare providers to a detailed frequency and voiding diary with avoiding score which is easily transferred to a mobile device and uploaded to a cloud server. Stream Dx's goal is to assists urologists and primary care physicians identify and treat aging males suffering from Lower Urinary Tract Symptoms (LUTS) by providing them with efficient quantitative tools to individualize treatment plans, reduce costs and improve patient outcomes. Stream Dx was founded in 2014 and is headquartered in Salt Lake City, Utah, USA.

Vita Inclinata Technologies, Inc. is an aerospace company specializing in solutions for helicopter hoisting and sling load control systems. Founded in 2019 and headquartered in Broomfield, Colorado, with additional offices in Seattle, Washington, and Estonia, the company develops autonomous systems aimed at improving safety and efficiency in helicopter operations across various sectors, including aerospace and construction. Its innovative rescue hoisting system incorporates a proprietary control algorithm that is integrated into the stabilization computer of the helicopter. This technology effectively mitigates the swinging motion of the cable and load, allowing rescuers and medical personnel to provide care with greater stability and precision during critical rescue missions.

Kineta, Inc. is a clinical-stage biotechnology company based in Seattle, Washington, focused on developing immunology-based therapies for various diseases, including oncology, neuroscience, and virology. The company is advancing several innovative treatments, such as KCP-506, an antagonist for chronic pain, and LHF-535, an oral antiviral therapy effective against Lassa virus and other arenaviruses. Additionally, Kineta is working on drug development programs targeting RIG-I and VISTA to enhance immune responses against cancer. Founded in 2007, the company has established strategic partnerships with major corporations in the pharmaceutical industry to further its research and development efforts.

OtoNexus Medical Technologies Inc. specializes in the design, development, and commercialization of a patented ultrasound medical device aimed at diagnosing middle ear infections, also known as otitis media, in both children and adults. This innovative device provides clinicians with the ability to differentiate between viral and bacterial infections, facilitating informed decisions regarding the necessity of antibiotics. By employing ultrasound technology in a novel manner, the device delivers rapid diagnosis in seconds and can be utilized by various healthcare professionals, including physicians and non-physician personnel. Additionally, the incorporation of one-use-per-patient tips generates a recurring revenue stream for the company. Founded in 2010 and based in Seattle, Washington, OtoNexus Medical Technologies was previously known as OtoMetrix Medical Technologies before rebranding in July 2014.

StormSensor, Inc. is a company based in Seattle, Washington, that specializes in stormwater management solutions aimed at tracking and preventing flooding, sewage overflows, and other stormwater issues. Founded in 2015, it develops Scute sensors that provide real-time monitoring of stormwater systems. Additionally, StormSensor offers Terrapin, a cloud-based software platform that allows users to visualize data on maps and time-series, correlate it with real-time weather information, and receive alerts for significant flow events. This system automates workflow for inspections, data monitoring, and regulatory reporting, thereby helping clients streamline compliance processes in a complex regulatory environment. By providing critical insights into urban flooding, illicit discharges, and the impacts of climate change, StormSensor enables its clients to respond effectively to climate-driven risks and make informed decisions regarding infrastructure maintenance and improvements.

Textile-Based Delivery, Inc., operating under the name Nufabrx, specializes in the development and manufacturing of fabrics embedded with medications and therapeutic substances. The company offers a range of products, including bamboo pillowcases infused with tea tree oil and lavender that release these ingredients during sleep. Its innovative approach extends to various textile applications, such as headbands, wristbands, socks, shirts, shorts, underwear, shoes, leggings, athletic apparel, and swimwear. Nufabrx utilizes five patent-pending technologies that facilitate the secure and controlled release of essential oils, vitamins, and cosmeceuticals over extended periods, even enduring numerous laundering cycles. Founded in 2011, the company is headquartered in Seattle, Washington, with an additional office in Minneapolis, Minnesota.

Blaze Bioscience, Inc. is a biotechnology company based in Seattle, Washington, focused on developing innovative products to assist surgeons in treating cancer patients. The company specializes in tumor paint technology, which enhances real-time visualization of cancer cells during surgery. Its lead product candidate, BLZ-100, combines a targeting peptide with a fluorescent dye that emits near-infrared light, facilitating the identification and precise resection of tumors across various solid tumor types, including brain, breast, prostate, lung, colorectal, skin, and sarcoma cancers. Founded in 2010, Blaze Bioscience aims to improve surgical outcomes by enabling better detection of cancerous tissues while preserving surrounding healthy tissue.

Novuson, Inc. is a medical technology company based in Bothell, Washington, specializing in the development of ultrasonic surgical devices. Founded in 2014 as a spinout from the University of Washington’s Applied Physics Laboratory, Novuson focuses on its Direct Therapeutic Ultrasound (DTU) technology platform, which is designed to provide coagulation and hemostatic control during surgical and trauma procedures. The company’s product lineup includes an ultrasonic clamp, a beam ablation/cauterization probe, and a precision beam ultrasonic scalpel, all of which enable clinicians to treat or remove tumors and manage bleeding in solid organs and highly vascularized tissues effectively. By utilizing focused ultrasound energy, Novuson’s devices facilitate rapid hemostasis, cauterization, and division, thereby reducing operational costs and enhancing patient outcomes while minimizing complications related to bleeding.

American Semiconductor, Inc. is a semiconductor foundry based in Boise, Idaho, specializing in the development and fabrication of flexible integrated circuits (ICs) and advanced packaging technologies. Founded in 2001, the company provides a range of services including wafer fabrication, process development, and custom IC manufacturing. Its offerings encompass Flexfet CMOS technology, flexible silicon-on-polymer solutions, and multi-project wafer programs. American Semiconductor is recognized for its expertise in ultra-thin device technology, enabling the creation of lightweight, flexible electronic systems. The company serves design firms that require foundry services for custom IC designs and integrated device manufacturers. Additionally, it licenses its proprietary Flexfet independent double gated transistor technology to other businesses, further contributing to advancements in the semiconductor industry.

ActX, Inc. is a company based in Seattle, Washington, founded in 2012, that specializes in integrating genomic information into clinical practice. The company focuses on providing actionable clinical insights derived from patients' genetic data, which helps healthcare providers personalize medical care. ActX offers services that include the collection and analysis of saliva samples, ensuring that genetic information is securely stored and privately managed. This enables physicians to access relevant genomic insights either through electronic medical records or a secure online platform, thereby enhancing patient care and improving health outcomes.

Resonance AI is a company that specializes in artificial intelligence and analytics, focusing on video content analysis. Founded in 2013 and headquartered in Seattle, Washington, the company has developed a platform that utilizes machine learning to dissect various elements of videos, including dialogue and music. This technology enables Resonance AI to provide insights into audience engagement and preferences, helping businesses understand the connection between their content and viewer behaviors. The platform is adaptable to different types of video content, such as TV shows, trailers, and advertisements, allowing companies to make informed decisions that can enhance viewer engagement, subscriptions, and sales.

Aqueduct Critical Care, founded in 2013 and based in Bothell, Washington, focuses on developing medical devices aimed at improving the management of inter-cranial pressure (ICP) in patients with neurological diseases related to cerebral spinal fluid. The company's innovative devices utilize gravity-based drainage systems to automate the regulation of ICP, reducing the need for constant manual monitoring and adjustments. This advancement not only enhances patient mobility but also allows hospital staff to conduct necessary tests and physical therapy with minimal intervention, thereby optimizing care and reducing the demands on nursing resources.

WhiteSpace Health, Inc. specializes in data analytics and cloud-based healthcare intelligence solutions for healthcare providers. The company offers a comprehensive business management system that includes tools for measuring physician performance, enhancing operational efficiencies, and improving financial metrics. Their solutions enable healthcare organizations to track and improve utilization, cycle times, quality, safety, and compliance with regulatory requirements. By leveraging a cloud-based visual data analytics platform, WhiteSpace Health converts diverse data points into actionable key performance indicators, allowing providers to respond effectively to the evolving healthcare landscape and consumer demands. Founded in 2014, the company is headquartered in Durham, North Carolina, with additional operations in Seattle, Washington, and a development facility in Hyderabad, India. As of March 2017, WhiteSpace Health operates as a subsidiary of Omega Healthcare Management Services Private Limited.

Tilting Motor Works, Inc. specializes in developing leaning three-wheel conversion solutions for motorcycles, enhancing their stability and safety without compromising performance. Founded in 2008 and headquartered in Snohomish, Washington, the company replaces the front fork and wheel of traditional motorcycles with a new front end that integrates various components, including shocks, wheels, tires, brakes, and hydraulic systems. This patented retrofit aims to provide riders with an improved riding experience by offering higher performance and increased confidence on the road. With a focus on safety and stability, Tilting Motor Works continues to innovate in the motorcycle modification industry.

Tectonic Audio Labs Inc. designs and manufactures innovative loudspeakers tailored for various applications, including audiovisual rentals, touring, and religious settings. The company specializes in flat-panel loudspeakers, offering models such as the PL-11 for small to medium venues and the PL-12 for larger spaces. In addition to loudspeakers, Tectonic provides rigging systems, mounting solutions, and speaker cases, catering to markets like clubs, theaters, churches, auditoriums, corporate events, sports venues, and festivals. Utilizing patented technologies, such as distributed mode loudspeakers and balanced mode radiators, Tectonic's products deliver high-quality audio experiences. Founded in 2011 and headquartered in Woodinville, Washington, the company sells its products primarily through dealers in the United States.

Monitor Mask Inc. is a medical device company based in Seattle, Washington, that specializes in manufacturing and selling face mask solutions for CO2 sampling in sidestream capnography during sedation anesthesia. Founded in 2012, the company primarily serves hospitals, ambulatory surgery centers, operating rooms, emergency departments, post-anesthesia care units, intensive care units, emergency medical services, and catheterization laboratories. Its flagship product, the M1 Capnography Mask, inspired the CapnoVue face mask series, which is designed to enhance patient safety by monitoring carbon dioxide levels in a patient's breath. The masks feature pre-formed ports that allow for accurate assessment of oxygen supply, thereby enabling clinicians to improve patient safety and streamline care workflows. Monitor Mask operates as a subsidiary of Salter Labs Inc.

LumiThera, Inc. is a medical device company based in Poulsbo, Washington, established in 2013. The company specializes in developing innovative treatment solutions aimed at improving visual function and preventing vision loss and blindness associated with various ocular diseases. LumiThera's primary product is The Valeda, a light delivery system that utilizes photobiomodulation (PBM) to treat dry age-related macular degeneration (AMD) and other eye disorders. By employing non-invasive light-emitting diodes (LEDs), LumiThera offers therapies designed to enhance visual acuity and contrast sensitivity while reducing the volume of central drusen. The company's focus is on both acute and chronic ocular conditions, with the goal of stopping or slowing the progression of debilitating eye diseases.

Precision Image Analysis, Inc., based in Kirkland, Washington, specializes in cloud-based remote medical image post-processing and analysis services for diagnostic medical studies, particularly in CT and MRI imaging. Founded in 2012, the company serves healthcare institutions, universities, and research organizations, providing timely analysis that can be delivered in as little as two hours. Its HIPAA-compliant platform allows users to upload images and monitor their analyses remotely, ensuring efficient workflow and standardized reporting. Precision Image Analysis offers particular expertise in cardiac, vascular, and neuro imaging, allowing healthcare providers to manage image analysis tasks without the need for additional staffing or extensive training on new technology. This capability enables clients to scale their image analysis efforts flexibly and cost-effectively, addressing fluctuations in demand without compromising on quality or efficiency.

Minetta Brook develops software that enables users to navigate, discover, and track relevant information from large bodies of data. Through their patent-pending machine learning & linguistics technology, their core engine can be applied to information sources such as streaming news, enterprise document repositories, defense agency data, and social & web content to combine both unstructured and structured data to allow for analysis of a complete picture. It was founded in 2011 and headquartered in Kirkland, Washington.

OtoNexus Medical Technologies Inc. specializes in the design, development, and commercialization of a patented ultrasound medical device aimed at diagnosing middle ear infections, also known as otitis media, in both children and adults. This innovative device provides clinicians with the ability to differentiate between viral and bacterial infections, facilitating informed decisions regarding the necessity of antibiotics. By employing ultrasound technology in a novel manner, the device delivers rapid diagnosis in seconds and can be utilized by various healthcare professionals, including physicians and non-physician personnel. Additionally, the incorporation of one-use-per-patient tips generates a recurring revenue stream for the company. Founded in 2010 and based in Seattle, Washington, OtoNexus Medical Technologies was previously known as OtoMetrix Medical Technologies before rebranding in July 2014.

Kineta, Inc. is a clinical-stage biotechnology company based in Seattle, Washington, focused on developing immunology-based therapies for various diseases, including oncology, neuroscience, and virology. The company is advancing several innovative treatments, such as KCP-506, an antagonist for chronic pain, and LHF-535, an oral antiviral therapy effective against Lassa virus and other arenaviruses. Additionally, Kineta is working on drug development programs targeting RIG-I and VISTA to enhance immune responses against cancer. Founded in 2007, the company has established strategic partnerships with major corporations in the pharmaceutical industry to further its research and development efforts.

Overlake Capital is an asset management firm that specializes in providing diverse and high-yield investment services to institutions, individuals, and financial professionals. Founded in 2007, the firm originally emerged from the creation of Empower, a groundbreaking financial services company. In response to growing demand for innovative investment opportunities, Overlake Capital launched its flagship fund in 2012 and adopted its current name in 2014 to reflect its commitment to the local Seattle-Bellevue community. The firm places a strong emphasis on understanding and prioritizing clients' needs, crafting tailored investment solutions aligned with individual goals. Overlake Capital is dedicated to continuous improvement in service and performance, ensuring that partners work closely with clients to establish and achieve relevant investment objectives.

VetDC, Inc. is a veterinary biotechnology company dedicated to cancer research and the development of innovative treatments for companion animals, specifically dogs and cats. Founded in 2009 and based in Fort Collins, Colorado, VetDC focuses on creating therapies targeting various cancers, including lymphoma, sarcomas, and solid tumors. The company offers novel acyclic nucleotide analogues and dual-acting inhibitors designed to attack cancerous cells. VetDC's mission is to facilitate the rapid advancement of anti-cancer therapies, providing veterinarians with access to effective, FDA-approved treatments for their patients. By combining human biomedical technology with veterinary needs, VetDC aims to improve the quality of life for pets and support their families during cancer treatment.

Pyatt Broadmark Management is based in Seattle and offers private loans for real estate financing in Washington, Oregon and Idaho. Pyatt Broadmark Management has proven to be a valuable resource for builders, ‘fix and flip’ investment buyers and developers who require quick closings, “outside the box thinking” and the utmost professional service. At Pyatt Broadmark Management, they develop trust with their borrowers based on communication, careful underwriting and fair pricing. That is why they experience so much repeat business and long-term relationships with borrowers. Whether financing single-family homes, tracts of homes or commercial real estate, their experience and personal approach allow us to respond quickly to client needs, and resolve the issues that inevitably arise in real estate development. From initial financing through project completion, Pyatt Broadmark works alongside clients to ensure their success. Whether negotiating with a third-party lender, ensuring adequate reserves for maintenance and repairs, or addressing environmental concerns, they will be your advocate throughout the process.

NuvoMed offers a patented, disposable device called the DisImpactorTM, developed for the safe, fast, and effective relief of fecal impaction with maximum comfort and clinical efficacy. The company is committed to improving this unpleasant procedure for both the patient and physician. By significantly reducing the pain for the patient while providing a more capable tool for the physician, NuvoMed intends to provide the ultimate solution. The company was founded in 2012 and is based in Seattle, Washington.

KPI Therapeutics, Inc. is a biotechnology company specializing in the development of therapies for unmet medical needs, particularly in the fields of autoimmunity and chronic pain. The company offers several drug candidates, including dalazatide, KPI-150, and KPI-190, targeting systemic autoimmune diseases such as lupus, as well as a CSP conopeptide aimed at managing chronic pain. Founded in 2013 and based in Seattle, Washington, KPI Therapeutics collaborates with various partners, including Kineta, Inc., Chimera Biotec, and the University of Washington School of Medicine, to enhance drug development and improve access to new treatments. The company is committed to accelerating the progression of promising drug candidates through critical stages of development, addressing significant gaps in patient care.

Pebblebee, founded in 2013 and based in Seattle, Washington, specializes in trackable technologies for both consumers and enterprises. The company develops smart tracking devices designed to monitor valuable items, providing users with peace of mind. Pebblebee's products are characterized by their long battery life and ease of attachment to various belongings, allowing individuals and businesses to efficiently track their possessions.

Asius Technologies develops, protects, and markets a system of in-ear technology through its product ADEL. ADEL (Ambrose Diaphonic Ear Lens) inflates in the ear and enables users to experience a high sound quality when used with hearing aids, headsets, and earbuds. The patented Ambrose Diaphonic Ear Lens ADES" consists of a polymer bubble, which is inserted into the ear canal and inflated to fit. This produces a comfortable, one size fits all, seal with minimum occlusion effect for the coupling of an audio device (hearing aid, digital music player, cell phone, communications headset) to the ear. Asius Technologies is based in Colorado, United States.

U Grok It, Inc. specializes in developing a smartphone-based radio-frequency identification (RFID) solution, which includes a hardware device that connects to iOS and Android devices, a supporting application, and a cloud-based backend. This platform allows users to identify, track, and manage physical objects efficiently, enabling inventory management and item location through mobile technology. U Grok It’s solution is particularly valuable in the context of the Internet of Things, as it facilitates the digitization and connectivity of the physical world. The company provides a robust software development kit that empowers developers to incorporate RFID functionality into their applications. Founded in 2011, U Grok It operates from Steamboat Springs, Colorado, with additional offices in San Francisco and Seattle, distributing its products through authorized resellers.

PetHub, Inc. specializes in digital pet identification solutions, primarily through its innovative tags and collars designed to reunite lost pets with their owners. Founded in 2010 and headquartered in Wenatchee, Washington, the company offers accessories such as tag connectors and silencers alongside its core products. PetHub’s digital tags leverage smartphone technology, allowing individuals to scan the tag and access the pet's profile, which includes vital information like care instructions and medical conditions. The service boasts a high success rate, with 98% of lost animals returning home without entering shelters, and 96% of them being reunited within 24 hours. PetHub's unique approach also includes instant alerts to owners when their pets are found and the ability to send electronic lost pet posters to local shelters. With a significant market of pet owners in the U.S., PetHub has been recognized for its innovation and effectiveness in pet safety solutions.

Minetta Brook develops software that enables users to navigate, discover, and track relevant information from large bodies of data. Through their patent-pending machine learning & linguistics technology, their core engine can be applied to information sources such as streaming news, enterprise document repositories, defense agency data, and social & web content to combine both unstructured and structured data to allow for analysis of a complete picture. It was founded in 2011 and headquartered in Kirkland, Washington.

Orahealth Corp. develops products for the treatment and prevention of diseases and ailments of the mouth. It offers XyliMelts for dry mouth; CankerMelts for the treatment of canker sores; and Avamin Melts, a mouth lining. The company provides its products through retail and online locations. Orahealth Corp. was incorporated in 2001 and is based in Bellevue, Washington.

Vega Performance Marketing, Inc. is a digital media services agency and affiliate marketing network that specializes in cost-per-action (CPA) marketing. Established in 2007 and headquartered in Seattle, Washington, the company offers a range of managed services that include performance marketing programs, technology infrastructure, and campaign management. Vega Performance Marketing collaborates with a global community of online media partners and direct response marketers to deliver optimized marketing solutions for client advertisers, which include agencies and other marketing service providers. The firm has developed partnerships with notable entities and provides direct distribution through various media channels, enhancing its service offerings in the competitive landscape of digital marketing.

SkyKick, Inc. is a provider of cloud-based migration solutions aimed at assisting IT consultants, system integrators, managed service providers, and value-added resellers in transitioning enterprise customers to the cloud. Founded in 2011 and based in Seattle, Washington, the company offers a suite of applications designed to streamline cloud migration processes. Key offerings include Web Planner, which facilitates sales assessment and planning; Migration Manager, which oversees migration projects; and Cloud Manager, an automation and management tool. SkyKick's software automates Microsoft Office 365 migrations, data backups, and service management, helping IT partners enhance operational efficiency and expand service offerings. The company’s technology also includes tools for managing email, calendar, and contacts during migrations, ensuring a smooth transition for clients.

Funium, a Provo, Utah-based Facebook games developer. The flagship game is Family Village, which is currently in Alpha testing. A limited beta test is planned for Q2 2011.

AdSpore operates a smartphone application that provides users access to digital coupons across the University of Washington campus. The application utilizes a gaming format that encourages users to locate and collect "spores," which represent discounts, rebates, and prizes. By engaging with the application, students can discover promotional offers from local businesses in an interactive manner. This platform not only enhances the shopping experience for users but also serves as a cost-effective marketing channel for businesses, facilitating connections through promotions, events, and other communications.

Cadence Biomedical, headquartered in Seattle, WA, is an early-stage medical device company that is committed to helping the 2.3 million Americans who suffer severe mobility impairments to gain a more mobile and independent life. Cadence Biomedical's primary commercial product, Kickstart, is a neurorehabilitation device designed to accelerate recovery to walking in stroke, multiple sclerosis, spinal cord injury patients, and individuals with other progressive neurological conditions. Kickstart is available for use in physical therapy during the initial recovery process and as a prescribed device for post-discharge use in the community and home settings. The company is currently developing a new class of device, a kinetic orthosis, based on a novel exotendon technology invented at the Cleveland Clinic by world-renowned researcher Dr. A.J. van den Bogert. Cadence closed its first round of funding in August 2010 (as Empowering Engineering Technologies, Corp.) and signed a perpetual, worldwide exclusive license agreement with the Cleveland Clinic to develop and market the technology. Market release of the kinetic orthosis is expected in early 2012.

Cadence Biomedical, headquartered in Seattle, WA, is an early-stage medical device company that is committed to helping the 2.3 million Americans who suffer severe mobility impairments to gain a more mobile and independent life. Cadence Biomedical's primary commercial product, Kickstart, is a neurorehabilitation device designed to accelerate recovery to walking in stroke, multiple sclerosis, spinal cord injury patients, and individuals with other progressive neurological conditions. Kickstart is available for use in physical therapy during the initial recovery process and as a prescribed device for post-discharge use in the community and home settings. The company is currently developing a new class of device, a kinetic orthosis, based on a novel exotendon technology invented at the Cleveland Clinic by world-renowned researcher Dr. A.J. van den Bogert. Cadence closed its first round of funding in August 2010 (as Empowering Engineering Technologies, Corp.) and signed a perpetual, worldwide exclusive license agreement with the Cleveland Clinic to develop and market the technology. Market release of the kinetic orthosis is expected in early 2012.

Valant Medical Solutions Inc. offers a web-based electronic health record (EHR) and billing system specifically designed for behavioral health professionals, including psychiatrists, psychologists, and therapists in the United States. Founded in 2005 and based in Seattle, the company provides a comprehensive platform that includes tools for scheduling patient visits, customizing documents, and generating practice management reports. Key features of Valant's system include a Mobile Notes tool for point-of-care documentation, a Patient Portal for patient engagement, and Easy Billing software for efficient electronic billing. Additionally, the platform offers automatic appointment reminders and an electronic prescription module to streamline prescription management. By leveraging cloud technology, Valant aims to enhance administrative and clinical efficiency for its clients, enabling them to focus on improving patient outcomes.

Pyatt Broadmark Management is based in Seattle and offers private loans for real estate financing in Washington, Oregon and Idaho. Pyatt Broadmark Management has proven to be a valuable resource for builders, ‘fix and flip’ investment buyers and developers who require quick closings, “outside the box thinking” and the utmost professional service. At Pyatt Broadmark Management, they develop trust with their borrowers based on communication, careful underwriting and fair pricing. That is why they experience so much repeat business and long-term relationships with borrowers. Whether financing single-family homes, tracts of homes or commercial real estate, their experience and personal approach allow us to respond quickly to client needs, and resolve the issues that inevitably arise in real estate development. From initial financing through project completion, Pyatt Broadmark works alongside clients to ensure their success. Whether negotiating with a third-party lender, ensuring adequate reserves for maintenance and repairs, or addressing environmental concerns, they will be your advocate throughout the process.

Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Seattle, Washington, that focuses on developing innovative therapies for breast health conditions, including breast cancer. The company is advancing its lead drug, Endoxifen, an active metabolite of tamoxifen, which is currently in Phase II clinical trials aimed at treating and preventing breast cancer. In addition to Endoxifen, Atossa is working on intraductal microcatheter technology designed to deliver therapies, such as fulvestrant and immunotherapies, directly to cancer sites. The company also has ongoing projects targeting COVID-19, including AT-H201, intended to improve lung function in hospitalized patients, and AT-301, a nasal spray for at-home treatment of COVID-19. Founded in 2009, Atossa Therapeutics was previously known as Atossa Genetics and rebranded in January 2020.

NanoICE, Inc. specializes in the design and manufacture of advanced ice production machines, salt-water dosing systems, and ice storage tanks. The company has developed Molecular Ice Technology, which creates microscopic ice particles from salt water to enhance the preservation of fresh products. This innovative technology serves various sectors, including food producers, transporters, storage companies, retail grocers, restaurants, and hotels, addressing modern challenges related to food preservation. NanoICE aims to achieve three main objectives: preserving natural resource yields to maximize market products, reducing the risk of foodborne illnesses without the need for chemicals, and promoting sustainable practices through partnerships with industry stakeholders. Founded in 2010 and based in Tukwila, Washington, NanoICE distributes its products through a network of distributors.

Enroute Systems Corporation is a transportation management system company that offers Software-as-a-Service (SaaS) solutions for multi-carrier shipping. Founded in 2008 and based in Seattle, Washington, the company provides tools such as the Enroute Portal, which optimizes shipment execution for a range of shippers, and the Enroute Platform, an XML-based service that enables application access to its functionalities. Additionally, Enroute Systems offers services like Enroute InStore, which assists retail staff in fulfilling web orders and transferring products, and Enroute Inbound, which facilitates shipments from vendors to retail locations. The company's Enroute Analytics tool enhances supply chain visibility by converting shipping data into actionable insights. Enroute Systems is recognized for its capabilities in shipment management, including rules-based carrier selection, label creation, and shipment tracking, making it a valuable partner for online retailers.

Delve Networks, founded by Alex Castro, in Seattle is an online video platform, that acquired 280+ customers including the NFL, Cleveland Clinic, Prudential, Pokemon, Lego, Fidelity, Kansas City Chief and delivered 200 million streams per month. Delve Networks was acquired by Limelight Networks in 2010 and Delve became a business unit within Limelight (and remained based in Seattle). Delve's CEO, Alex Castro, continued to lead the business and Vice President and General Manager of the Limelight Video Platform business unit. Many of Delve's employees came from Amazon, Yahoo, and Google. Delve's VP of Product Development, Edgardo Nazario, was an early employee of storage company, Isilon Systems, which was backed by Sequoia and acquired by EMC. Previously, Edgardo worked at early video pioneer, Real Networks. Delve' founder, Alex Castro was at Amazon where he launched Mechanical Turk. Prior to that he was at Microsoft where he launched the initial version of Microsoft CRM and worked on Windows Client and Internet Explorer. Delve's board included Mark Klebanoff, a former Seattle venture capitalist and the CFO who took Real Networks public. Post acquisition, the Delve video platform business experienced strong growth in worldwide customers and revenue. Delve founder and CEO, Alex Castro, eventually joined Electronic Arts as a Vice President. Edgardo Nazario is current a Senior Vice President at Limelight Networks.

Onehub Inc. specializes in providing secure online sharing and collaboration solutions tailored for small and medium-sized businesses. Founded in 2007 and based in Seattle, Washington, the company offers a cloud-based file storage and sharing service that features customizable storage spaces, granular sharing permissions, and collaborative tools such as task assignments and comments. This service allows users to easily organize, store, and share files across various devices, including iPhones, iPads, and Android devices. In addition to its primary service, Onehub also provides Marshal, a free data loss prevention tool that helps businesses identify exposed sensitive data threats within their cloud accounts. With over 1.6 million business users relying on its services, Onehub aims to equip organizations with effective tools for managing and securing their data.

Healionics Corporation, founded in 2007 and based in Seattle, Washington, specializes in the development and manufacturing of synthetic biomaterials and implantable medical devices aimed at improving healthcare for kidney failure patients. The company has created STARport HD, an implantable device that enables needle-free access to the bloodstream for hemodialysis, and STARgraft, a synthetic vascular graft designed to maintain long-term blood flow without frequent interventions. Healionics' innovations address critical challenges in dialysis treatment, particularly the unreliability of current vascular access methods, which can lead to costly complications. Their STAR biomaterial technology enhances the performance of medical implants by reducing infection and scar tissue formation. Healionics is preparing to initiate human studies for its products, with a focus on improving patient outcomes and reducing overall treatment costs in the dialysis sector.